MichaelR.BristowMD
Cardiology • Denver, COAdult Congenital Heart Disease, Interventional Cardiology
Professor, Medicine, University of Colorado School of Medicine
Are you Dr. Bristow?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 56 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4200 E 9th Ave
Denver, CO 80262Phone+1 303-493-7000- Is this information wrong?
Summary
- Dr. Michael Bristow, MD is a cardiologist in Denver, Colorado. He is currently licensed to practice medicine in Colorado, Utah, and California. He is a Professor at University of Colorado School of Medicine.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Cardiovascular Disease, 1977 - 1979- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1976 - 1977
- Stanford Health Care-Sponsored Stanford UniversityInternship, Internal Medicine, 1971 - 1972
University of Illinois College of MedicineClass of 1970
Certifications & Licensure
CA State Medical License 1973 - Present
CO State Medical License 1991 - 2025
UT State Medical License 1984 - 1992- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1985
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Effect of Beta-blockers on Structural Remodeling and Gene Expression in the Failing Human Heart Start of enrollment: 2000 Sep 01
- Pulse Reduction On Beta-blocker and Ivabradine Therapy Start of enrollment: 2016 Nov 01
Publications & Presentations
PubMed
- Training the Next Generation of Data Monitoring Committee Members: An Initiative of the Heart Failure Collaboratory.Thomas R Fleming, Janet Wittes, Mona Fiuzat, Frank W Rockhold, Jason T Connor, Benjamin R Saville, Brian Claggett, Isabella Cavagna, Thomas D Cook, Christopher O'Conno...> ;JACC. Heart Failure. 2024 Mar 23
- Rewarding Site-Based Research: A Step Toward Improving the Ecosystem of Heart Failure Clinical Trials.Matthew G Dimond, Mona Fiuzat, Anu Lala-Trindade, Patrice Desvigne-Nickens, Christopher M O'Connor, Mentz, R., Whellan, D., Walsh, M., Costanzo, M., Yehya, A., Malik, ...> ;JACC. Heart Failure. 2024 Jan 1
- 1 citationsHow carvedilol does not activate β-adrenoceptors.Robert J Lefkowitz, Howard A Rockman, Paul J Shim, Samuel Liu, Seungkirl Ahn, Biswaranjan Pani, Sudarshan Rajagopal, Sudha K Shenoy, Michel Bouvier, Jeffrey L Benovic,...> ;Nature Communications. 2023 Nov 30
- Join now to see all
Authored Content
- Dynamic Regulation of SARS-CoV-2 Binding and Cell Entry Mechanisms in Remodeled Human Ventricular MyocardiumJune 2020
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure — NEJMMay 1996
Press Mentions
Heart Failure Strategically Focused Research Network: Summary of Results and Future DirectionsSeptember 8th, 2022
Anne Prener, M.D., Ph.D. Appointed to Renovacor Board of Directors and Scientific Advisory BoardFebruary 24th, 2020
Cover Story | What's Your Path?September 20th, 2019- Join now to see all
Grant Support
- Beta-Blocker Effect On Remodeling And Gene ExpressionNational Center For Research Resources2004–2008
- Genetic-Adrenergic Interactions In Myocardial FailureNational Heart, Lung, And Blood Institute2004–2007
- Dynamic Expression Profiling In The Intact Human HeartNational Heart, Lung, And Blood Institute2002–2003
- Altered Gene Expression In The Failing Human HeartNational Heart, Lung, And Blood Institute1999–2003
- Effects Of Chronic Trtmnt WI Bucindolol HCL Or Metoprolol TartrateNational Center For Research Resources1999–2002
- Contractile Protein Expression In Failing Human HeartNational Heart, Lung, And Blood Institute1998–2002
- Beta Adrenergic Blockade In Patients With Congestive Heart FailureNational Center For Research Resources1996–2002
- Parallel, Dose RESP Study--Sustnd Released Moxonidine In CHF PatientsNational Center For Research Resources1999–2000
- Efficacy Of IV Milrinone In Patients With Congestive Heart FailureNational Center For Research Resources1998–2000
- Postgraduate Training In Cardiovascular ResearchNational Heart, Lung, And Blood Institute1996–2000
- Adrenergic Mechanisms In The Intact Failing Human HeartNational Heart, Lung, And Blood Institute1993–1996
- Therapy With And Withdrawal Of Beta Adrenergic Blockade In PT W Conge Heart FailNational Center For Research Resources1995
- OPC 18790 In Subjects With Heart FailureNational Center For Research Resources1993–1995
- A Dose Range Finding Study Of Intravenous 349u85 HCL In Congestive Heart FailureNational Center For Research Resources1993–1995
Professional Memberships
- Member
